Carlsmed, Inc. CARL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.51M | -8.70M | -8.61M | -8.53M | -6.77M |
| Total Depreciation and Amortization | 130.00K | 99.00K | 98.00K | 82.00K | 61.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.75M | 2.78M | 1.54M | 1.49M | 1.52M |
| Change in Net Operating Assets | -732.00K | -7.19M | 1.65M | -1.50M | -1.85M |
| Cash from Operations | -7.36M | -13.01M | -5.32M | -8.46M | -7.04M |
| Capital Expenditure | -121.00K | -79.00K | -73.00K | -159.00K | -327.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.54M | -127.00K | -24.16M | -184.00K | -345.00K |
| Cash from Investing | -19.66M | -206.00K | -24.23M | -343.00K | -672.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 243.00K | 436.00K | 21.00K | 93.47M | 34.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -50.00K | -2.76M | -2.28M |
| Cash from Financing | 243.00K | 436.00K | -29.00K | 90.70M | -2.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.77M | -12.78M | -29.58M | 81.90M | -9.96M |